Two developments signal expanding genomic infrastructure globally. MGI Tech signed an MoU with South African agencies to launch the 110K Human Genome Program, installing a high‑throughput DNBseq‑T7 to build a national genomic reference and enable multi‑omics research. Separately, Geneseeq secured NMPA authorization for a sequencing‑based PanTRKare kit as China’s first pan‑tumor CDx for NTRK fusions, validated across thousands of samples and multiple tumor types.